NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC fell 2.2%, and the Danish
In the past week, the Mobility and Energy Production & Storage sectors did very well – again. The best-performing stock is about to be acquired
In the past week, the Mobility and Energy Production & Storage sectors did very well. The best-performing stocks were driven by Q1 results, a collaboration
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, Genmab and Zealand Pharma received new price
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was full of exciting news. Genmab announced
In the past week, the mobility and food & beverage sectors did well. Especially the fishing stocks had a good performance, and if the fishing
The CO2 & Carbon Capture sector stood out as the best-performing sector in the past week. Multiple companies entered into new collaborations, agreements on expansion
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week Genmab announced a USD 1.8 Billion acquisition
Several sectors had strong performance the past week with almost 10% increases. Aker Carbon Capture rose following a major joint venture/merger, and NEL received MUSD
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was influenced by easter with only 3.5
Kapital Partner A/S
Christian IX's Gade 10, 4. th
1111 København K
CVR: 37364843
Kapital Partner performs or has within the last 12 months performed corporate finance, market relations, investor relations, Certified Adviser or other advisory activities for the following listed companies: NORD.investments, Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.